Literature DB >> 4004886

Diclofenac binding to albumin and lipoproteins in human serum.

J M Chamouard, J Barre, S Urien, G Houin, J P Tillement.   

Abstract

The binding of diclofenac to human serum albumin (HSA) and to lipoproteins was studied in vitro by equilibrium dialysis. Binding to HSA is characterized by two classes of sites with one site each (K1 = 5 X 10(5) M-1 and K2 = 0.6 X 10(5) M-1). The binding to lipoproteins was shown to be saturable with a larger number of binding sites and low association constants. The evidence of two specific binding sites on HSA was confirmed by circular dichroism data. In addition, an identification of those sites was performed by displacement of fluorescent probes. The data show that the high affinity site (K1 = 5 X 10(5) M-1) is likely to be shared by benzodiazepines while the second one (K2 = 0.6 X 10(5) M-1) is common with the warfarin site.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4004886     DOI: 10.1016/0006-2952(85)90636-7

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  11 in total

Review 1.  Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls.

Authors:  N M Davies; K E Anderson
Journal:  Clin Pharmacokinet       Date:  1997-09       Impact factor: 6.447

2.  Serum protein binding of nonsteroidal antiinflammatory drugs: a comparative study.

Authors:  O Borgå; B Borgå
Journal:  J Pharmacokinet Biopharm       Date:  1997-02

3.  Mass spectrometric characterization of circulating covalent protein adducts derived from a drug acyl glucuronide metabolite: multiple albumin adductions in diclofenac patients.

Authors:  Thomas G Hammond; Xiaoli Meng; Rosalind E Jenkins; James L Maggs; Anahi Santoyo Castelazo; Sophie L Regan; Stuart N L Bennett; Caroline J Earnshaw; Guruprasad P Aithal; Ira Pande; J Gerry Kenna; Andrew V Stachulski; B Kevin Park; Dominic P Williams
Journal:  J Pharmacol Exp Ther       Date:  2014-06-05       Impact factor: 4.030

4.  Characterizing protein domain associations by Small-molecule ligand binding.

Authors:  Qingliang Li; Tiejun Cheng; Yanli Wang; Stephen H Bryant
Journal:  J Proteome Sci Comput Biol       Date:  2012-12-03

5.  Pharmacokinetics of diclofenac and misoprostol when administered alone or as a combination product.

Authors:  A Karim
Journal:  Drugs       Date:  1993       Impact factor: 9.546

6.  Circular dichroism simulation shows a site-II-to-site-I displacement of human serum albumin-bound diclofenac by ibuprofen.

Authors:  K Yamasaki; M H Rahman; Y Tsutsumi; T Maruyama; S Ahmed; U Kragh-Hansen; M Otagiri
Journal:  AAPS PharmSciTech       Date:  2000-05-14       Impact factor: 3.246

7.  Inhibiting low-density lipoprotein glycation ameliorates increased cholesteryl ester synthesis in macrophages and hypercholesterolemia and aortic lipid peroxidation in streptozotocin diabetic rats.

Authors:  Margo P Cohen; Elizabeth A Shea; Van-Yu Wu
Journal:  Metabolism       Date:  2009-11-18       Impact factor: 8.694

8.  Interaction of benzothiadiazides with human serum albumin studied by dialysis and spectroscopic methods.

Authors:  N Takamura; M H Rahman; K Yamasaki; M Tsuruoka; M Otagiri
Journal:  Pharm Res       Date:  1994-10       Impact factor: 4.200

Review 9.  Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-03       Impact factor: 9.546

10.  Effect of itraconazole on the pharmacokinetics of diclofenac in beagle dogs.

Authors:  Fahad I Al-Jenoobi
Journal:  Sci Pharm       Date:  2010-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.